Unexpected absence of the Epstein-Barr virus (EBV) lyLMP-1 open reading frame in tumor virus isolates: Lack of correlation between Met129 status and EBV strain identity

Journal of Virology

Volumn 77, Issue 7, 2003, Pages 4415-4422

  Erickson, Kimberly D ^a   Berger, Christoph ^b   Coffin III, William F ^a   Schiff, Edwin ^a   Walling, Dennis M ^c   Martin, Jennifer M ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b UNIVERSITY CHILDREN S HOSPITAL   (Switzerland)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LATENT MEMBRANE PROTEIN 1;

ARTICLE; CODON; EPSTEIN BARR VIRUS; NONHUMAN; ONCOVIRINAE; OPEN READING FRAME; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; STRAIN DIFFERENCE; VIRUS ISOLATION; VIRUS STRAIN;

BASE SEQUENCE; CELL LINE; CODON; CONSERVED SEQUENCE; DNA, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; EVOLUTION, MOLECULAR; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; METHIONINE; MOLECULAR SEQUENCE DATA; OPEN READING FRAMES; SPECIES SPECIFICITY; VIRAL MATRIX PROTEINS;

EID: 0037377732     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.77.7.4415-4422.2003     Document Type: Article

References (54)

1. Adler, B., E. Schaadt, B. Kempkes, U. Zimber-Strobl, B. Baier, and G. W. Bornkamm. 2002. Control of Epstein-Barr virus reactivation by activated CD40 and viral latent membrane protein 1. Proc. Natl. Acad. Sci. USA 99:437-442.
2. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95-8 Epstein-Barr virus genome. Nature 310:207-211.
3. Baichwal, V. R., and B. Sugden. 1987. Posttranslational processing of an Epstein-Barr virus-encoded membrane protein expressed in cells transformed by Epstein-Barr virus. J. Virol. 61:866-875.
4. Berger, C., D. van Baarle, M. J. Kersten, M. R. Klein, A. S. Al-Homsi, B. Dunn, C. McQuain, R. van Oers, and H. Knecht. 1999. Carboxy-terminal variants of Epstein-Barr virus encoded latent membrane protein 1 during long term HIV infection: reliable markers for individual strain identification. J. Infect. Dis. 179:240-244.
5. Biggin, M., M. Bodescot, M. Perricaudet, and P. Farrell. 1987. Epstein-Barr virus gene expression in P3HR1-superinfected Raji cells. J. Virol. 61:3120-3132.
6. Chang, Y. S., P. J. Chung, C. J. Shu, C. K. Ng, S. J. Wu, and S. T. Liu. 1995. Detection of an Epstein-Barr-virus variant in T-cell-lymphoma tissue identical to the distinct strain observed in nasopharyngeal carcinoma in the Taiwanese population. Int. J. Cancer 62:673-677.
7. Chen, M. L., C. N. Tsai, C. L. Liang, C. H. Shu, C. R. Hang, D. Sulitzeanu, S. T. Liu, and Y. S. Chang. 1992. Cloning and characterization of the latent membrane protein (LMP) of a specific Epstein-Barr virus variant derived from the nasopharyngeal carcinoma in the Taiwanese population. Oncogene 7:2131-2140.
8. Cheung, S.-T., S.-F. Leung, K.-W. Lo, K. W. Chiu, J. S. L. Tam, T. F. Fok, P. J. Johnson, J. C. K. Lee, and D. P. Huang. 1998. Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. Int. J. Cancer 76:399-406.
9. Cheung, S.-T., K.-W. Lo, S. F. Leung, W.-Y. Chan, P. H. K. Chio, P. J. Johnson, J. C. K. Lee, and D. P. Huang. 1996. Prevalence of LMP1 deletion variant of Epstein-Barr virus in nasopharyngeal carcinoma and gastric tumors in Hong Kong. Int. J. Cancer 66:711-712.
10. Desgranges, C., G. de The, H. Wolf, and H. zur Hausen. 1975. Further studies on the detection of the Epstein-Barr virus DNA in nasopharyngeal carcinoma biopsies from different parts of the world. IARC Sci. Publ. 11:191-193.
11. Edwards, R. H., F. Seillier-Moiseiwitsch, and N. Raab-Traub. 1999. Signature amino acid changes in latent membrane protein 1 distinguish Epstein-Barr virus strains. Virology 261:79-95.
12. Eliopoulos, A. G., and A. B. Rickinson. 1998. Epstein-Barr virus: LMP1 masquerades as an active receptor. Curr. Biol. 8:R196-R198.
13. Erickson, K. D., and J. M. Martin. 1997. Early detection of the lytic LMP-1 protein in EBV-infected B-cells suggests its presence in the virion. Virology 234:1-13.
14. Erickson, K. D., and J. M. Martin. 2000. The late lytic LMP-1 protein of Epstein-Barr virus can negatively regulate LMP-1 signaling. J. Virol. 74:1057-1060.
15. Farrell, P. J. 1998. Signal transduction from the Epstein-Barr virus LMP-1 transforming protein. Trends Microbiol. 6:175-178.
16. Fennewald, S., S. van Santen, and E. Kieff. 1984. Nucleotide sequence of an mRNA transcribed in latent growth-transforming virus infection indicates that it may encode a membrane protein. J. Virol. 51:411-419.
17. Fielding, C. A., K. Sandvej, A. Mehl, P. Brennan, M. Jones, and M. Rowe. 2001. Epstein-Barr virus LMP-1 natural sequence variants differ in their potential to activate cellular signaling pathways. J. Virol. 75:9129-9141.
18. Hammerschmidt, W., B. Sugden, and V. R. Baichwal. 1989. The transforming domain alone of the latent membrane protein of Epstein-Barr virus is toxic to cells when expressed at high levels. J. Virol. 63:2469-2475.
19. Hatfull, G., A. T. Bankier, B. G. Barrell, and P. J. Farrell. 1988. Sequence analysis of Raji Epstein-Barr virus DNA. Virology 164:334-340.
20. Henle, G., W. Henle, G. Klein, P. Gunven, P. Clifford, R. H. Morrow, and J. L. Ziegler. 1971. Antibodies to early Epstein-Barr virus-induced antigens in Burkitt's lymphoma. J. Natl. Cancer Inst. 46:861-871.
21. Hu, L., F. Chen, F. Zheng, I. Ernberg, S. Cao, B. Christensson, G. Klein, and G. Winberg. 1993. Clonability and tumorigenicity of human epithelial cells expressing the EBV-encoded membrane protein LMP1. Oncogene 8:1575-1583.
22. Hu, L., B. Troyanovsky, X. Zhang, I. Ernberg, and G. Klein. 2000. Differences in the immunogenicity of latent membrane protein 1 (LMP1) encoded by Epstein-Barr virus genomes derived from LMP1-positive and -negative nasopharyngeal carcinoma. Cancer Res. 60:5589-5593.
23. Hu, L.-F., E. R. Zabarovsky, F. Chen, S.-L Cao, I. Ernberg, G. Klein, and G. Winberg. 1991. Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP-1) from a Chinese nasopharyngeal carcinoma. J. Gen. Virol. 72:2399-2409.
24. Hu, L. F., F. Chen, Q.-F. Zhen, Y.-W. Zhang, Y. Luo, X. Zheng, G. Winberg, I. Ernberg, and G. Klein. 1995. Differences in the growth pattern and clinical course of EBV-LMP1 expressing and nonexpressing nasopharyngeal carcinomas. Eur. J. Cancer 31A:658-660.
25. Hudson, G. S., P. J. Farrell, and B. G. Barrell. 1985. Two related but differentially expressed potential membrane proteins encoded by the EcoRI Dhet region of Epstein-Barr virus B95-8. J. Virol. 53:528-535.
26. Huen, D. S., S. A. Henderson, D. Croom-Carter, and M. Rowe. 1995. The Epstein-Barr virus latent membrane protein (LMP1) mediates activation of NF-κB and cell surface phenotype via two effector regions in its carboxyterminal cytoplasmic domain. Oncogene 10:549-560.
27. Khanim, F., Q. Y. Yao, G. Niedobitek, S. Sihota, A. B. Rickinson, and L. S. Young. 1996. Analysis of Epstein-Barr virus gene polymorphisms in normal donors and in virus-associated tumors from different geographic locations. Blood 88:3491-3501.
28. Kieff, E. 1996. Epstein-Barr virus and its replication, 3rd ed. Raven Press, Lid., Philadelphia, Pa.
29. Kingma, D. W., W. B. Weiss, E. S. Jaffe, S. Kumar, K. Frekko, and M. Raffeld. 1996. Epstein-Barr virus latent membrane protein-1 oncogene deletions: correlation with malignancy in Epstein-Barr virus-associated lymphoproliferative disorders and malignant lymphomas. Blood 88:242-251.
30. Knecht, H., E. Bachmann, P. Brousset, S. Rothenberger, J. Einsele, V. S. Lestou, G. Delsol, F. Bachmann, P. F. Ambros, and B. F. Odematt. 1995. Mutational hot spots within the carboxy terminal region of the LMP1 oncogene of Epstein-Barr virus are frequent in lymphoproliferative disorders. Oncogene 10:523-528.
31. Knecht, H., E. Bachmann, P. Brousset, K. Sandvej, D. Nadal, F. Bachmann, B. F. Odermatt, G. Delsol, and G. Pallesen. 1993. Deletions within the LMP1 oncogene of Epstein-Barr virus are clustered in Hodgkin's disease and identical to those observed in nasopharyngeal carcinoma. Blood 82:2937-2942.
32. Knecht, H., F. Matius, E. Bachman, T. Hoffman, D. R. Zimmerman, S. Rothenberger, K. Sandvej, W. Wegman, N. Hurwitz, B. F. Odermatt, H. Kummer, and G. Pallesen. 1995. A deletion mutant of the LMP-1 oncogene of Epstein-Barr virus is associated with evolution of angioimmunoblastic lymphadenopathy into B immunoblastic lymphoma. Leukemia 9:458-465.
33. Larcher, C., C. McQuain, C. Berger, M. Mitterer, P. J. Quesenberry, H. P. Huemer, and H. Knecht. 1997. Epstein-Barr virus-associated persistent polyclonal B-cell lymphocytosis with a distinct 69 base pair deletion in the LMP1 oncogene. Ann. Hematol. 74:23-38.
34. Leung, S. Y., S. T. Yuen, L. P. Chung, A. S. Y. Chan, and M. P. Wong. 1997. Prevalence of mutations and 30 bp deletion in the C-terminal region of Epstein-Barr virus latent membrane protein-1 oncogene in reactive lymphoid tissue and non-nasopharyngeal EBV-associated carcinomas in Hong Kong Chinese. Int. J. Cancer 72:225-230.
35. Liebowitz, D., J. Mannick, K. Takada, and E. Kieff. 1992. Phenotypes of Epstein-Barr virus LMP1 deletion mutants indicate transmembrane and amino-terminal cytoplasmic domains necessary for effects in B-lymphoma cells. J. Virol. 66:4612-4616.
36. Miller, G., and M. Lipman. 1973. Release of infectious Epstein-Barr virus by transformed marmoset leukocytes. Proc. Natl. Acad. Sci. USA 70:190-194.
37. Miller, W. E., R. H. Edwards, D. M. Walling, and N. Raab-Traub. 1994. Sequence variation in the Epstein-Barr virus latent membrane protein 1. J. Gen. Virol. 75:2729-2740.
38. Mitchell, T., and B. Sugden. 1995. Stimulation of NF-κB-mediated transcription by mutant derivatives of the latent membrane protein of Epstein-Barr virus. J. Virol. 69:2968-2976.
39. Moorthy, R., and D. Thorley-Lawson. 1993. Biochemical, genetic and functional analyses of the phosphorylation sites on the Epstein-Barr virus-encoded oncogenic latent membrane protein LMP-1. J. Virol. 67:2637-2645.
40. Pallesen, G., S. J. Hamilton-Dutolt, M. Rowe, and I. S. Young. 1991. Expression of Epstein-Barr virus latent gene products in tumour cells of Hodgkin's disease. Lancet 337:320-322.
41. Rabson, M., L. Heston, and G. Miller. 1983. Identification of a rare Epstein-Barr virus variant that enhances early antigen expression in Raji cells. Proc. Natl. Acad. Sci. USA 80:2762-2766.
42. Rowe, D. T. 1999. Epstein-Barr virus immortalization and latency. Front. Biosci. 4:D346-D371.
43. Sample, J., E. F. Kieff, and E. D. Kieff. 1994. Epstein-Barr virus types 1 and 2 have nearly identical LMP-1 transforming genes. J. Gen. Virol. 75:2741-2746.
44. Sandvej, K., S. C. Peh, B. S. Anderson, and G. Pallesen. 1994. Identification of potential hot spots in the carboxy-terminal part of the Epstein-Barr virus (EBV) BNLF-1 gene in both malignant and benign EBV-associated diseases: high frequency of a 30 bp deletion in Malaysian and Danish peripheral T-cell lymphomas. Blood 84:4053-4060.
45. Sugden, B. 1984. Immune deficiency and cancer, p. 165-177. In D. T. Purtilo (ed.), Expression of virus-associated functions in cells transformed in vitro by Epstein-Barr virus: Epstein-Barr virus cell surface antigen and virus-release from transformed cells. Plenum Medical Book Co., New York, N.Y.
46. Sugden, B. 1994. Latent infection of B lymphocytes by Epstein-Barr virus. Semin. Virol. 5:197-205.
47. Takada, K. 1984. Cross-linking of cell surface immunoglobulin induces Epstein-Barr virus in Burkitt lymphoma lines. Int. J. Cancer 33:27-32.
48. Torii, T., K. Konishi, J. Sample, and K. Takada. 1998. The truncated form of the Epstein-Barr virus LMP-1 is dispensable or complementable by the full-length form in virus infection and replication. Virology 251:273-278.
49. Trivedi, P., L. F. Hu, F. Chen, B. Christensson, M. G. Masucci, G. Klein, and G. Winberg. 1994. The Epstein-Barr virus (EBV)-encoded membrane protein LMP1 from a nasopharyngeal carcinoma is nonimmunogenic in a murine model system, in contrast to a B-cell-derived homologue. Eur. J. Cancer 30A:84-88.
50. Walling, D. M., N. Shebib, S. C. Weaver, C. M. Nichols, C. M. Flaitz, and J. Webster-Cyriaque. 1999. The molecular epidemiology and evolution of Epstein-Barr virus: sequence variation and genetic recombination in the latent membrane protein-1 gene. J. Infect. Dis. 179:763-764.
51. Wang, D., D. Liebowitz, and E. Kieff. 1988. The truncated form of the Epstein-Barr virus latent-infection membrane protein expressed in virus replication does not transform rodent fibroblasts. J. Virol. 62:2337-2346.
52. Wang, D., D. Liebowitz, F. Wang, C. Gregory, A. Rickinson, R. Larson, T. Springer, and E. Kieff. 1988. Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J. Virol. 62:4173-4184.
53. Weigel, R., and G. Miller. 1983. Major EB virus-specific cytoplasmic transcripts in a cellular clone of the HR-1 Burkitt's lymphoma line during latency and after induction of virus replicative cycle by phorbol esters. J. Virol. 125:287-298.
54. Wilson, G., and G. Miller. 1979. Recovery of Epstein-Barr virus from nonproducer neonatal human lymphoid cell transformants. Virology 95:351-358.